Inactive Instrument
Sector dividends LYSOGENE
Stocks
LYS
FR0013233475
Biotechnology & Medical Research
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 5.53M | |
| -.--% | -.--% | -18.4x | 5.67x | 9.26x | -18.44x | -16.68x | 3.98B | |
| -.--% | -.--% | -44.58x | 24.66x | 13.01x | 836.76x | -62.76x | 3.87B | |
| -.--% | -.--% | 38.36x | 2.39x | 4.87x | 17.87x | 35.19x | 3.42B | |
| -.--% | -.--% | -23.8x | 3.93x | 5.39x | 33.7x | -76.83x | 1.09B | |
| 3.6% | 3.89% | 16.43x | 1.43x | 2.01x | 7.04x | 12.27x | 1.08B | |
| -.--% | -.--% | -7.44x | 3.75x | 123.38x | -4.72x | -4.5x | 109M | |
| Average | 0.6% | 0.65% | -6.57x | 6.97x | 26.32x | 145.37x | -18.88x | 1.94B | |
| Weighted average by Cap. | 0.29% | 0.31% | -9.14x | 9.78x | 9.26x | 241.53x | -19.20x |
